Korsana Biosciences, Inc. (KRSA) Form 10-Q Quarterly Reports
Korsana Biosciences, Inc. (KRSA) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: KRSA
CIK: 1755237
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: MA
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Ernst & Young LLP
Auditor SinceSince 12/31/2017 12:00:00 AM
Lead Engagement PartnerWilliam Williamson
Audit LocationBoston, Massachusetts, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 10-Q | 2026-11-05 | 2026-09-30 | 10-Q | 0001193125-26-448636 | View SEC Doc Filr Page |
| 8-K | 2026-11-05 | 2026-11-05 | 8-K | 0001193125-26-448535 | View SEC Doc Filr Page |
| 144 | 2026-10-22 | — | 144 Filing | 0001950047-26-010364 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-10-15 | — | SCHEDULE 13G/A Filing | 0001493152-26-047257 | View SEC Doc Filr Page |
| DEF 14A | 2026-10-15 | 2026-11-13 | DEF 14A | 0001193125-26-422893 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-10-07 | — | SCHEDULE 13G/A Filing | 0000315066-26-002345 | View SEC Doc Filr Page |
| PRE 14A | 2026-10-05 | 2026-10-05 | PRE 14A | 0001193125-26-414133 | View SEC Doc Filr Page |
| 144 | 2026-09-23 | — | 144 Filing | 0001950047-26-009776 | View SEC Doc Filr Page |
| 144 | 2026-09-22 | — | 144 Filing | 0001950047-26-009757 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-09-18 | — | SCHEDULE 13G Filing | 0000950142-26-002568 | View SEC Doc Filr Page |
| 144 | 2026-09-18 | — | 144 Filing | 0001950047-26-009679 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-09-16 | — | SCHEDULE 13G Filing | 0001903360-26-000015 | View SEC Doc Filr Page |
| SCHEDULE 13D | 2026-09-15 | — | SCHEDULE 13D Filing | 0001738048-26-000069 | View SEC Doc Filr Page |
| SCHEDULE 13D | 2026-09-11 | — | SCHEDULE 13D Filing | 0001193125-26-389417 | View SEC Doc Filr Page |
| 8-K | 2026-09-11 | 2026-09-08 | 8-K | 0001193125-26-389318 | View SEC Doc Filr Page |
| 4 | 2026-09-10 | 2026-09-09 | 4 | 0001193125-26-388146 | View SEC Doc Filr Page |
| 4 | 2026-09-10 | 2026-09-09 | 4 | 0001193125-26-388144 | View SEC Doc Filr Page |
| 4 | 2026-09-10 | 2026-09-09 | 4 | 0001193125-26-388142 | View SEC Doc Filr Page |
| 4 | 2026-09-10 | 2026-09-09 | 4 | 0001193125-26-388136 | View SEC Doc Filr Page |
| 3 | 2026-09-10 | 2026-09-08 | 3 | 0001193125-26-388127 | View SEC Doc Filr Page |
| 3 | 2026-09-10 | 2026-09-08 | 3 | 0001193125-26-388126 | View SEC Doc Filr Page |
| 3 | 2026-09-10 | 2026-09-08 | 3 | 0001193125-26-388123 | View SEC Doc Filr Page |
| 3 | 2026-09-10 | 2026-09-08 | 3 | 0001193125-26-388120 | View SEC Doc Filr Page |
| 3 | 2026-09-10 | 2026-09-08 | 3 | 0001193125-26-388115 | View SEC Doc Filr Page |
| 3 | 2026-09-10 | 2026-09-08 | 3 | 0001193125-26-388112 | View SEC Doc Filr Page |